Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA’s Label Conversion Project Would Revise Data As Well As Reformat

This article was originally published in The Pink Sheet Daily

Executive Summary

Solicitation asks for contractor to reformat labels to physician labeling rule format, including updates with new information from literature; generic companies like contractor, while brands say it will be resource-intensive for industry and FDA.

Advertisement

Related Content

FDA’s Drug Labeling Decisions Complicated By Uncertain Target Audience, Limited Authority
FDA Wants All Drug Manufacturers To Adopt Highlights Labeling Format
Rx Labeling Final Rule Largely In Line With Draft Version

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS076000

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel